Sequential occurrence of non-small cell and small cell lung cancer with the same EGFR mutation

Ryotaro Morinaga, Isamu Okamoto, Kazuyuki Furuta, +7

Lung Cancer

Sequential OccurrenceNon-small CellTumor HeterogeneityMedicinePathology +9

Phase I Safety, Pharmacokinetic, and Biomarker Study of BIBF 1120, an Oral Triple Tyrosine Kinase Inhibitor in Patients with Advanced Solid Tumors

Isamu Okamoto, Hiroyasu Kaneda, Taroh Satoh, +12

Molecular Cancer Therapeutics

OncologyMedicineMalignant Blood DisorderHematologyAdvanced Solid Tumors +12

Acquisition of the T790M resistance mutation during afatinib treatment in EGFR tyrosine kinase inhibitor-naïve patients with non–small cell lung cancer harboring <i>EGFR</i> mutations

Kentaro Tanaka, Kaname Nosaki, Kohei Otsubo, +13

Oncotarget

Alectinib for Patients with ALK Rearrangement–Positive Non–Small Cell Lung Cancer and a Poor Performance Status (Lung Oncology Group in Kyushu 1401)

Eiji Iwama, Yasushi Goto, Haruyasu Murakami, +20

Journal of Thoracic Oncology

OncologyCancer ManagementPathologyPoor Performance StatusCancer Treatment +6

A Real-World Study on the Effectiveness and Safety of Pembrolizumab Plus Chemotherapy for Nonsquamous NSCLC

Daichi Fujimoto, Satoru Miura, Kenichi Yoshimura, +18

JTO Clinical and Research Reports

OncologyMedicinePembrolizumab Plus ChemotherapyImmune Checkpoint InhibitorNonsquamous Nsclc +5

Phase I clinical and pharmacokinetic study of sorafenib in combination with carboplatin and paclitaxel in patients with advanced non–small cell lung cancer

Isamu Okamoto, Masaki Miyazaki, Ryotaro Morinaga, +9

Investigational New Drugs

Association of epidermal growth factor receptor (<i>EGFR</i>) gene mutations with <i>EGFR</i> amplification in advanced non‐small cell lung cancer

Ryotaro Morinaga, Isamu Okamoto, Yoshihiko Fujita, +7

Cancer Science

PathologyCancer BiologyTumor BiologyCancer Cell BiologyMolecular Diagnostics +15

A phase I study of binimetinib (MEK162) in Japanese patients with advanced solid tumors

Koichiro Watanabe, Satoshi Otsu, Yoshinori Hirashima, +12

Cancer Chemotherapy and Pharmacology

Tumor BiologyOncologyMedicineCancer GrowthPathology +6

Phase II trial of weekly nab-paclitaxel for previously treated advanced non–small cell lung cancer: Kumamoto thoracic oncology study group (KTOSG) trial 1301

Shinya Sakata, Sho Saeki, Isamu Okamoto, +16

Lung Cancer

Trial 1301Phase Ii TrialMedicineMetronomic TherapyBronchial Neoplasm +5

Histologic transformation of epidermal growth factor receptor–mutated lung cancer

Daichi Fujimoto, Hiroaki Akamatsu, Takeshi Morimoto, +29

European Journal of Cancer

Tumor BiologyPathologyMedicineCancer GrowthLung Cancer +1